Clinical Trials Browser

LY2584702 × Clear all

NCT01115803 2019-02-05

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Phase 1 Terminated

29 enrolled 19 charts

EndocrineGenitourinaryNETThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT01394003 2019-01-18

A Study of LY2584702 in Participants With Advanced Cancer

Phase 1 Terminated

34 enrolled 18 charts

Advanced Cancer

NCT01241461 2018-08-21

A Study of LY2584702 in Solid Tumors

Phase 1 Completed

9 enrolled 9 charts

Neoplasm Metastasis, Neoplasms